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            Amendments from Version 2
In this version of the paper we have tried again to highlight the 
difference between impaired renal function and chronic kidney 
disease, and why this distinction is not made in the majority of 
epidemiological studies, and why the utility of the concept of CKD 
may be different in sub-Saharan Africa. We have also added more 




Chronic kidney disease (CKD) is an under-recognized non-
communicable disease, associated with a high morbidity and 
mortality. It is estimated that one in ten people are living with 
kidney disease worldwide and the prevalence may be higher in 
low-income countries such as Uganda1,2. However, as shown in a 
recent systematic review the quality of data is often poor, 
frequently using convenience samples in high-risk populations3. 
Furthermore, only 2% of the studies included in this review used 
the CKD-EPI equation for calculation of estimated glomerular 
filtration rate (eGFR) which, based on limited data, has been 
found to be the best estimate of population CKD prevalence3,4. 
There is little distinction between impaired renal function 
and chronic kidney diseases in most of the studies from sub- 
Saharan Africa where these two are used interchangeably3. It is 
thus more appropriate to use impaired renal function rather 
than CKD when creatinine and albuminuria are meas-
ured once with no repeated measure to comfirm chronicity. 
Community-based studies of the prevalence of impaired renal 
function have shown marked variation in results. Among peo-
ple living with HIV/AIDS, estimates range from 0.7% in Rakai, 
Central Uganda, 14.4% in Gulu, Northern Uganda, 26.5% in 
Zambia to 41.3% in Tanzania5–8. Among HIV-negative popula-
tions, estimates range from 2.5% in Wakiso, Central Uganda to 
26.5% in Tanzania8,9. Hospital-based studies from a National 
Referral Hospital in Uganda show that most patients with kidney 
disease are young and have advanced disease by the time of 
presentation10. Thus, in sub-Saharan Africa estimates of kidney 
disease prevalence vary widely depending on the methods 
used to determine renal function and the population studied, in 
particular the age distribution8,11–19.
Globally, among the known key risk factors for CKD are 
diabetes mellitus, hypertension and infections such as HIV. 
Hypertension and HIV are important problems in Uganda with 
hypertension prevalence estimated to be 26.4%20 and rising 
among those with HIV-infection21. However, the prevalence of 
diabetes mellitus is low compared to high-income countries at 
2%22. Moreover, some studies have also highlighted differences 
in the prevalence of impaired renal function between urban 
and rural areas in Africa. A study from Cameroon found the 
overall prevalence of CKD to be 13.2%: 14.1% and 10.9% among 
rural and urban dwellers, respectively23. Late diagnosis, along 
with limited health care leading to poor control of hypertension 
and diabetes may be possible drivers of a higher prevalence in 
rural populations.
Therefore, we aimed to determine the prevalence and associa-
tions of impaired renal function among a representative sample 
of a rural area of Uganda, within an existing population cohort 
using high quality sampling methods.
Methods
Study design and setting
The General Population Cohort (GPC) was established in 1989, 
by the United Kingdom Medical Research Council and the 
Uganda Virus Research Institute, in Kalungu District, South-
western Uganda24. The cohort was initially established to 
examine prevalence, incidence, risk factors and trends of infec-
tion with HIV in a rural African population. More recently, 
research activity has broadened to include the epidemiology 
and genetics of other communicable and of non-communicable 
diseases, including cancer, cardiovascular disease and diabetes24,25. 
In brief, the GPC is a community-based open cohort study 
of residents of 25 neighbouring villages within one-half 
of a sub-county, lying about 40 km from Lake Victoria. 
The population is scattered across the countryside in villages 
defined by administrative boundaries, with a few concentrated 
in small trading centres. The population under survey includes 
approximately 22,000 people, less than half of whom are more 
than 13 years of age. The cohort is dynamic with new births, 
deaths and migration reported at each round of follow-up. Data 
are collected through an annual census, an annual question-
naire and serological survey from 1989–2011 and a biennial 
questionnaire and serological survey thereafter. Details of sexual 
behaviour, medical, sociodemographic and geographic factors 
are recorded. Blood specimens are obtained at each biennial 
survey. Serum is tested for HIV-1 and the remainder is stored at 
-80°C. Since 1989, the seroprevalence of HIV has remained 
relatively stable in this population, with about 8% of participants 
infected; in recent years, prevalence has risen slightly, with the 
roll out of antiretroviral therapy and consequent improvements 
in survival.
All eligible participants were evaluated for the study with an 
acceptance rate of 98%. A total of 6,397 participants were indenti-
fied in the two rounds of the GPC (2011–2012 and 2014–2015) 
with 5,979 (93.5%) individuals having valid creatinine results. 
The 418 who did not have valid creatinine did not differ 
significantly from those selected. Variables used for analysis 
were extracted from two rounds, and participants’ information 
gathered from questionnaire and laboratory data of the survey 
rounds were linked by unique identifiers. For adults (18+ years 
for males and 16+ years for females), variables used to develop 
a socioeconomic score (SES), smoking status, alcohol consump-
tion, fruit and vegetable intake and results of Hepatitis B and C 
tests were derived from the 2011–2012 survey round. Variables 
associated with participant’s eGFR, age, maximum education level, 
current marital status, history of stroke, body mass index (BMI) 
and HIV status were based on the 2014–2015 survey round.
Data collection
Data collected from the GPC questionnaire regarding sexual 
behaviour and lifestyle factors were self-reported (Supplementary 
File 1). Anthropometric measurements and blood tests were 
performed by trained interviewers/nurses using calibrated instru-
ments and following standard operating procedures. We adapted 
the World Health Organization (WHO) STEP-wise approach 
to surveillance questionnaire to obtain socio-demographic 
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characteristics, lifestyle (diet, tobacco, and alcohol consump-
tion), medical history and biophysical measurements. Blood 
pressure was measured using a digital sphygmomanometer 
(Omron M4-1). The participant had to be in a sitting position 
and the mean of the second and third readings taken at 5-minute 
intervals was used for analysis. Body weight was measured using 
the Seca 761 mechanical scales and body height was measured 
using a stadiometer to the nearest 1 kg and 0.1 cm, respectively. 
Both scales were calibrated according to manufacturer guidelines 
weekly.
Laboratory tests
Blood tests for haemoglobin, HIV screening, HbA1c, hepatitis 
B and C viruses, as well as the creatinine level were performed. 
Venous blood was tested for haemoglobin level using CT -5 
Coulter Ac.T 5diff AL (Autoloader) [Beckman Coulter, North 
America]. HIV testing was performed using an approved national 
algorithm26. Hepatitis B surface antigen, Hepatitis C antibody 
and creatinine level were tested using a Cobas e 601 Auto 
Analyzer (Roche Diagnostics, North America). Creatinine was 
measured using the Jaffe method traceable to an isotope dilu-
tion mass spectrometry method27. The MRC/UVRI Entebbe 
laboratories currently have laboratory accreditation through ISO 
15189 of the Kenya Accreditation Service, and are enrolled in 
external quality control programs for South Africa, America, 
Australia and the United Kingdom.
Definitions and classification
Each participant’s SES was derived from conducting principal 
component analysis (PCA) using variables relating to household 
infrastructure and property ownership. Urbanicity score used 
in this study was derived from a previous study using informa-
tion from the Round 22 survey28. BMI was classified accord-
ing to WHO categories (weight/height2: kg/m2): underweight 
(<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight 
(25.0–29.9 kg/m2) and obese (>30.0 kg/m2). Blood pressure (BP) 
classification was derived from the National Institute of Health 
guidelines: Pre-Hypertension was defined as having a systolic BP 
greater than 120mmHg but less than 140 mmHg, and a diastolic 
BP greater than 80 mmHg but less than 90 mmHg. Hyperten-
sion was defined as having a diastolic BP greater than or equal 
to 90 mmHg, systolic BP greater than or equal to 140 mmHg or 
being on treatment for high BP. Anaemia was defined as hav-
ing haemoglobin levels less than 130 g/l in men, 120 g/l in non- 
pregnant women, and 110 g/l in pregnant women. Diabetes 
mellitus was diagnosed by either having HbA1c >6.5%, through 
self-reported measures of being previously diagnosed with 
diabetes, or by current treatment for diabetes.
Classification of renal function
The estimated glomerular filtration rate (eGFR) was calculated 
using the CKD-Epi equation, without use of the coefficient 
for African Americans29. Impaired renal function was divided into 
five categories analogous to CKD stages, based on the National 
Kidney Foundation guidelines (without including proteinuria) 
as: normal eGFR (≥90 ml/min/1.73 m2); low eGFR (60–89 ml/
min/1.73 m2); moderately reduced eGFR (30–59 ml/min/1.73 m2); 
severely reduced eGFR (15–29 ml/min/1.73 m2); and kidney 
failure (eGFR <15 ml/min/1.73 m2)30. We have used impaired 
renal function for the study because we did not have a second 
creatinine after 3 or more months or measures of urinary protein 
excretion  to comfirm CKD.
Statistical analysis
Baseline characteristics were tabulated stratified by sex. The 
prevalence of impaired renal function was also age standardised 
using the WHO world population as the reference.
We used logistic regression to estimate odd ratios (OR), along 
with its 95% confidence intervals (95% CIs), to identify potential 
factors independently associated with CKD. A forward step-
wise approach was used in developing our multivariable model 
adjusting for age, sex, and all independent predictors of CKD.
We also conducted a secondary analysis to compare partici-
pants with eGFR<60 ml/min/1.73 m2 to those with normal renal 
function excluding individuals in the low eGFR category. The 
population attributable fraction (PAF) of impaired renal function 
was estimated for hypertension, and anaemia using the adjusted 
odds ratios from the final multivariable model.
All statistical analyses were performed using STATA 13 SE 
(Stata Corp, Texas, USA).
Ethical considerations
All study participants gave written informed consent to 
participate in the study. The study was approved by Uganda Virus 
Research Institute Research and Ethics Committee (UVRI-REC) 
and the Uganda National Council for Science and Technology 
(UNCST).
Results
Baseline characteristics of study participants
A total of 6,397 individuals participated in the Round 24 GPC 
survey in 2014–2015 and 5,979 (93.5%) individuals had valid 
creatinine test results. The average age of study participants 
was 39 years (range: 16 years to 103 years), consisting of 3,626 
(60.7%) females. The majority of patients had primary-level 
education (60.4%). HIV prevalence was 9.7% (males: 8.4%, 
females: 10.5%) within this study population, and about 40% of 
the population was classified as pre-hypertensive. The mean serum 
creatinine level of the study population was 66.3 mmol/l (95% 
CI 65.4–66.3), and using the CKD-EPI equation, the average 
eGFR was 109.3 ml/min/1.73 m2 (95% CI 108.8–109.9) (Table 1).
Prevalence of impaired renal function
The overall prevalence of eGFR <60 ml/min per 1.73 m2 was 
1.6% (95% CI 1.34–1.99). Of the respondents, 4,792 (80.2%) were 
classified as normal, 1,089 (18.2%) as low eGFR, 91 (1.5%) as 
moderately reduced eGFR, 4 (0.1%) as severely reduced eGFR, 
and 3 (0.1%) classified as having kidney failure (Figure 1, Table 2). 
The prevalence of impaired renal function among those over the age 
of 16, age-standardised to the WHO population, was 1.8%.
Factors associated with eGFR <60 ml/min per 1.73 m2
Age and sex adjusted associations with the presence of eGFR 
<60 ml/min per 1.73 m2 are shown in Supplementary Table 1. In 
multivariable analysis, older age, hypertension (OR 2.86; 95% 
CI 1.15-7.08) and anaemia (OR 2.14 ; 95% CI 1.12-4.09) were 
independently associated with eGFR <60 ml/min per 1.73 m2 (Table 3).
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<35 1,033 (43.90) 1,703 (46.97) 2,736 (45.77)
35–44 460 (19.55) 721 (19.88) 1,181 (19.74)
45–54 378 (16.02) 507 (13.98) 884 (14.79) 
55–64 244 (10.37) 336 (9.27) 580 (9.70) 
65–74 138 (5.86) 231 (6.37) 369 (6.17) 
75+ 101 (4.29) 128 (3.53) 229 (3.83) 
Max Education 
None 137 (5.82) 394 (10.87) 531 (8.88) 
Primary 1,488 (63.24) 2,122 (58.52) 3,610 (60.38) 
Secondary 570 (24.21) 946 (26.09) 1,516 (25.35) 
Higher Level 158 (6.71) 164 (4.52) 322 (5.38) 
Currently Married**
No 357 (20.62) 1,075 (36.68) 1,432 (30.72) 
Yes 1,373 (79.36) 1,856 (63.32) 3,229 (69.28) 
Urbanicity*1 
Quartile 1 513 (28.71) 756 (26.31) 1,259 (27.24) 
Quartile 2 468 (26.19) 733 (25.86) 1,201 (25.98) 
Quartile 3 436 (24.40) 697 (24.59) 1,133 (24.51) 
Quartile 4 370 (20.71) 659 (23.25) 1,029 (22.26) 
SES*2 
Lower 565 (35.76) 819 (32.79) 1,384 (33.94) 
Middle 521 (33.04) 833 (33.35) 1,354 (33.23) 
Upper 493 (31.20) 846 (33.87) 1,339 (32.83) 
BMI3** 
Normal weight 1,786 (76.47) 2,290 (65.84) 4,076 (70.11) 
Underweight 407 (17.42) 302 (8.68) 709 (12.19) 
Overweight 122 (5.22) 648 (18.63) 770 (13.24) 
Obese 21 (0.90) 238 (6.84) 259 (4.45) 
Blood Pressure*4 
Normal 668 (40.44) 1,235 (48.82) 1,903 (45.51) 
Pre-Hypertension 719 (43.52) 944 (37.28) 1,663 (39.75) 





Negative 2,150 (91.57) 3,242 (89.51) 5,392 (90.32) 
Positive 198 (8.43) 380 (10.49) 578 (9.68) 
Hepatitis B* 
Negative 1,588 (96.48) 2,479 (98.10) 4,067 (97.46) 
Positive 58 (3.52) 48 (1.90) 106 (2.54) 
Hepatitis C* 
Negative 1,582 (96.17) 2,439 (96.52) 4,021 (96.38) 
Positive 63 (3.83) 88 (3.48) 151 (3.62) 
Anaemia*5 
Negative 1,078 (86.87) 1,583 (83.40) 2,661 (84.77) 
Positive 163 (13.13) 315 (16.60) 478 (15.23) 
Diabetes*6 
No 1,603 (97.74) 2,467 (97.94) 4,070 (97.53) 
Yes 37 (2.26) 52 (2.06) 89 (2.14) 
Current smoking status* 
Not current smoker 1,301 (78.80) 2,478 (97.87) 3,779 (90.34) 
Non-daily smoker 83 (5.03) 17 (0.67) 100 (2.39) 
Daily smoker 267 (16.17) 37 (1.46) 304 (7.27) 
Alcohol consumption* 
Never drinkers 831 (54.64) 1,589 (69.27) 2,420 (63.43) 
No alcohol in past 
30 days 
90 (5.92) 250 (10.90) 340 (8.91) 
Alcohol in past  
30 days 
600 (39.45) 455 (19.83) 1,055 (27.65) 
*Variables from a previous round (R22) of the GPC where total number of 
participants may vary: Urbanicity (n=4,622), SES (n=4,077), Blood Pressure 
(BP) (n=4,184), Hepatitis B (n=4,173), Hepatitis C (n=4,172), smoking 
status (n=4,183), alcohol consumption in the last 30 days (n=3,815), and 
anaemia (n=3,139). 1Urbanicity score derived from Riha et al. (2014). 
2Socio-economic Score (SES) derived from conducting Principle Component 
Analysis (PCA) on a statistical software using variables relating to household 
infrastructure and property ownership 3Body Mass Index (BMI) Classification 
according to WHO (weight/height2: kg/m2): Underweight (<18.5 kg/m2), 
Normal weight (18.5–24.99 kg/m2), Overweight (25.0–29.99 kg/m2), Obese 
(>30.0 kg/m2). 4BP classification derived from the National Institute of Health 
guidelines: Pre-Hypertension was defined as having a systolic BP >120 
mmHg but <140 mmHg, and a diastolic BP >80 mmHg but <90 mmHg. 
Hypertension was defined as having a systolic BP ≥90 mmHg, diastolic BP 
≥140 mmHg. 5Anaemia was defined as having haemogloblin levels less than 
130 g/L in men, 120 g/L in non-pregnant women, and 110 g/L in pregnant 
women. Only 2,064 individuals had anaemia results from the R24 of the GPC
6Diabetes was defined as having HbA1C >6.5%, or being previously 
diagnosed with diabetes, or are currently on treatment for diabetes. 
**Variables in R24 with missing individuals: Currently Married (n=4,661), BMI 
(n=5,814), HIV (n=5,970)
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Serum creatinine (mg/dl) 0.75 (0.74–0.75)
eGFR (ml/min/1.73m2)
   CKD-EPI equation*1 109.3 (108.8–109.9)
   MDRD equation* 106.2 (105.4–107.1)
Individuals n(%)
Category of level of eGFR
Normal eGFR (≥90 ml/min per 1.73 m2) 4,792 (80.15)
Low eGFR (60–89 ml/min per 1.73 m2) 1,089 (18.21)
Moderately reduced eGFR (30–59 ml/min per 1.73 m2) 91 (1.52)
Severely reduced eGFR (15–29 ml/min per 1.73 m2) 4 (0.07)
Kidney Failure (eGFR <15 ml/min per 1.73 m2) 3 (0.05)
*The CKD-EPI eGFR calculations were used as the primary outcomes in this study; the 
MDRD equation was used to contrast the difference between the two equations. 1The 
coefficient for black race was omitted while using this equation.
Age and sex adjusted associations of variables with the presence 
of eGFR of <90 mls/min/1.73m2 are shown in Supplementary 
Table 2. In multivariable analysis, female sex (OR 1.56, 95% 
CI 1.27-1.93); older age, higher urbanicity score, being overweight 
or obese; having hypertension (OR 1.60, 95 % CI 1.22-2.11) and 
HIV-positive status (OR 1.55, 95% CI 1.13-2.04) were associated 
with impaired kidney function (Supplementary Table 3).
Comparison of participants with eGFR <60 ml/min/1.73m2 to 
those with eGFR >90 ml/min/1.73m2 revealed that older age, 
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*Variables from a previous round (R22) of the GPC where total 
number of participants may vary: Blood Pressure (n=3,039). 
1Multivariable model adjusted for age, sex and all independent 
predictors of eGFR <60mls/min per 1.73 m2. OR, odds ratio; 95% CI, 
95% confidence interval. 2Blood pressure classification derived from 
the National Institute of Health guidelines: Pre-Hypertension was 
defined as having a systolic blood pressure greater than 120 mmHg 
but less than 140 mmHg, and a diastolic blood pressure greater 
than 80 mmHg but less than 90 mmHg. Hypertension was defined 
as having a systolic blood pressure (BP) greater than or equal to 
90mmHg, diastolic BP greater than or equal to 140mmHg. 3Anaemia 
was defined as having haemoglobin levels less than 130 g/l in men, 
120 g/L in non-pregnant women, and 110 g/l in pregnant women. 
Only 2,064 individuals had anaemia results from the R24 of the GPC
hypertension and anaemia were independently associated with 
impaired renal function (Supplementary Table 4).
The adjusted population attributable fraction of decreased 
renal function attributable to hypertension and anaemia was 
26.4% and 12.8%, respectively.
Discussion
We found a prevalence of eGFR <60 mL/min per 1.73 m2 of 
1.64% in this predominantly young rural community of Uganda 
with more than one-fifth of the study participants having eGFR 
<90 mL/min per 1.73 m2. Impaired renal function was strongly 
associated with age, high blood pressure and anaemia.
Comparing different prevalence estimates of impaired renal 
function from studies across sub-Saharan Africa is challeng-
ing for many reasons. In a meta-analysis of CKD in sub-Saharan 
Africa by Stanifer et al.3 the overall prevalence was 13.9% but the 
majority of the studies were conducted among patients with 
known risk factors for renal disease such as diabetes mellitus, 
HIV infection and hypertension. Furthermore, only 2% of the 
included studies used the CKD-EPI equation for calculation of 
eGFR although, based on limited data, it has been found to be the 
best estimate of population CKD prevalence3,4. The age structure 
of population varies widely between countries in sub-Saharan 
Africa making standardisation to a reference population crucial 
for comparisons between regions or countries. In addition, the 
prevalence of risk factors such as HIV infection vary substan-
tially across and within countries. We found a lower prevalence 
of of eGFR <60 mL/min per 1.73 m2 in this rural setting than 
would be expected according to previous studies3,23. This unex-
pected finding could be explained by the characteristics of the 
population under study. Over 66% of our study participants were 
less than 45 years of age yet CKD prevalence increases with 
age. The traditional risk factors for CKD like diabetes mellitus, 
hypertension, obesity, alcohol intake and smoking were low in 
our population (see Table 1).
We found that older age, hypertension and anaemia were associ-
ated with impaired renal function. Age is known to be strongly 
associated with eGFR3,23,29. Hypertension is both a cause and 
a consequence of kidney disease, and in this cross-sectional 
survey it was not possible to tell whether the participants had 
hypertension as a cause or consequence of the kidney disease. 
However there has been a rise in reported levels of hyperten-
sion in Uganda, from 13.7%31 in 1969 to 26.4% in 201520. 
Anaemia is also often a consequence of kidney disease, or may 
be due to shared risk-factors such as other chronic diseases. We 
found that anaemia was associated with kidney disease, even 
for patients with eGFR <90 ml/min/1.73m2, a level of kidney 
function at which a direct causal effect would not be anticipated. 
We only measured creatinine on one occasion while two results 
of eGFR <60 mL/min per 1.73 m2 more than 3 months apart 
are required for the formal definition of CKD. This may have 
led to an overestimate of the prevalence of impaired renal func-
tion. However, most large scale epidemiological surveys have 
also used one measurement of creatinine32. In addition, our study 
was prospectively sampled from well people and are thus 
likely to be affected by a transient fall in eGFR associated with 
acute illness. This is in contrast to many studies using routinely 
collected data to define renal function where misclassification 
is likely if blood tests are measured during when patients are 
unwell33. Even if we had two measures of creatinine we would 
not have been able to confidently assert that patients with eGFR 
<60 mL/min per 1.73 m2 had ‘chronic kidney disease’ as the 
estimating equations are not validated in sub-Saharan Africa 
and the long-term outcome implications, on which the CKD 
categorisation was defined, are not yet understood in this set-
ting. From the multivariable analysis hypertension and anae-
mia are likely manifestations of chronic kidney disease, so it 
is not unreasonable to presume that impaired kidney function 
is an estimate of CKD. It is also very difficult to have a repeat 
creatinine and urinalysis in community studies. More studies are 
needed to establish the utility of the second creatinine/urinary 
protein in establishing chronicity of kidney disease. There is 
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also need to put this in the context of poorly resourced coun-
tries where patients are likely to be lost to follow up. The initial 
contact may be the only opportunity to diagnose them  and put 
them into formal care with the aim of reducing progression to 
serious complications10.
Factors which have been traditionally associated with kidney 
disease in high-income countries such as smoking, alcohol 
intake and obesity were not associated with the presence of 
eGFR <60 mL/min per 1.73 m2 in this population. This may be 
because of the low prevalence of these factors in the community, 
or may suggest that the risk factors for CKD are different in this 
region. Indeed, other researchers have found that the majority 
of kidney disease in sub-Saharan Africa is not explained by tradi-
tional risk factors34.
Study strengths and limitations
This was a large community-based study conducted within a 
well-characterized population cohort. We used the CKD-Epi 
equation to determine eGFR, which is thought to be the best 
estimate of true GFR in sub-Saharan Africa. We measured 
a wide range of social and anthropometric factors, chronic 
diseases and biochemical measurements in a structured and 
validated manner. In addition, our prevalence estimates have 
been standardized to the WHO population to enable comparability 
with other studies across the world.
However, there were limitations, including lack of screening for 
urine abnormalities (proteinuria and hematuria) which could have 
led us to underestimate the prevalence of kidney disease. Newer 
classifications of CKD require measurement of proteinuria to 
define kidney disease4. We only measured creatinine on one occa-
sion while two results of eGFR <60 mL/min per 1.73 m2 more than 
3 months apart are required for the formal definition of CKD. 
This may have led to an overestimate of the prevalence of 
impaired renal function. 
Implications of the study
Interventions for end-stage renal disease are currently limited for 
most countries in sub-Saharan Africa with very poor access to 
dialysis and kidney transplantation9,35. This study has established 
a significant prevalence of impaired renal function, highlighting 
the need to focus efforts on preventive strategies to delay 
onset and slow progression of renal disease. However, marked 
uncertainty remains about how best to estimate GFR in black 
Africans. This highlights the importance of our ongoing 
prospective study to determine the best way to measure renal 
function in sub-Saharan Africa: http://blogs.lshtm.ac.uk/ark/.
Conclusions
We found that approximately one in five adults in rural Uganda 
had abnormal function despite a low prevalence of diabetes and 
obesity. More population based studies are needed to further 
characterize kidney disease in sub-Saharan Africa.
Data availability
Owing to data protection concerns, there are restrictions on 
access to the underlying data. The GPC database contains 
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and the LSHTM Research Unit or by email to mrc@mrcuganda.org 
or the corresponding author.
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A well written article and very relevant problem being questioned. The use of a General
Population Cohort which is well documented is an opportunity to follow them up further.
Use of the CKD epi formula is a good addition among published data in Africa. This work
could be indexed with some additional work.
I still think the article has important information to share to the scientific community even
though the disease has not been defined properly. Efforts to define the link between
impaired kidney function and CKD which is the assumed disease could be further made.
Why is impaired kidney function a poor man’s estimate of chronic kidney disease in a
community study? I note that this is somewhat discussed. More is needed to justify using
impaired kidney function and CKD interchangeably.
One way of looking at this is from the following argument derived from the authors’ data.
From the multivariable analysis hypertension and anaemia are likely manifestations of
chronic kidney disease, so it is not unreasonable to presume that impaired kidney
function is an estimate of CKD.
The study highlights the importance of determining the best way of estimating CKD from
the community. This statement could be more emphasized. This could be coming out as















This part explains very clearly the importance of CKD, the unavailability of quality data
and the variability of impaired renal function.
-          Again, in the flow of thoughts, the transition between CKD and impaired renal
function has not been linked.
-          The last sentence of the second paragraph “Late diagnosis………” appears to be
an original idea/conclusion. Rural populations have lower prevalence of CKD. (Stanifer et
al., 2015 ). This could be included in the discussion as well.
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As the last statement of the introduction emphasizes on high quality sampling methods, It
could be clearer how the authors sampled 5979 individuals from the 22,000 population.
What was the sampling method? The population is within a prospective cohort study. Is it
not true that the data collected was cross sectional?
Response
This has been further explained in the methods section.
All eligible participants were evaluated for the study with an acceptance rate of 98%. A total of
6,397 participants were identified in the two rounds the GPC (2011–2012 and 2014–2015 with
5,979 (93.5%) individuals having valid creatinine results. The 418 who did not have valid creatinine





The prevalence found of 1.6% is significantly low compared to the global prevalence of
CKD. This needs to be discussed in light of the definitions used. Impaired renal function
vs CKD. Remember while you hypothesize that the rural population have more CKD, this
cohort has very low levels of decreased eGFR. The strength would be in discussing this.
The second paragraph delineates why the results are not comparable, why not use
studies which used the same measure of impaired renal function? This is fair enough.
Were there papers in Stanifer that used CKD epi on population samples? Furthermore, the
use of MDRD to estimate the eGFR cannot explain such a huge difference in prevalence.
Again, this needs to come out.







“We found a lower prevalence of of eGFR <60 mL/min per 1.73 m  in this rural setting than would
be expected according to previous studies . This unexpected finding could be explained by the
characteristics of the population under study. Over 66% of our study participants were less than 45
years of age yet CKD prevalence increases with age. The traditional risk factors for CKD like
diabetes mellitus, hypertension, obesity, alcohol intake and smoking were quite low in our
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 that requires further exploration.
Conclusions
It was not clear from the study why more data on risk factors is needed. He is right to
point out that this is always a bit of a cop out. Need a stronger finishing sentence.
Response
This has been modified accordingly please see the conclusion section.
We found that approximately one in five adults in rural Uganda had abnormal kidney function
despite a low prevalence of diabetes and obesity. More population based studies are needed to
 further characterize kidney disease in SSA.
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Discussion: Study Strengths & Limitations, para 2, line 6. The sentence should read: “In addition our study
was prospectively sampled from well people and is this likely to be affected by any transient falls inun
eGFR associated with acute illness”
Discussion: Study Strengths & Limitations, para 2, line 8. The word   should be deleted. The‘during’
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